Kiniksa Pharmaceuticals International (KNSA) market cap

Market cap today
$7.47B

Kiniksa Pharmaceuticals International (KNSA) has a market cap of $7.47B. At the end of fiscal 2025 (December 31, 2025) its market cap was $3.26B. That is 130.6% higher than the $1.41B of fiscal 2024. Today's figure is 129.4% above the fiscal 2025 year-end. Figures as of 18 Nov 2026, 10:45 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Market cap today
$7.47B
Market cap, fiscal 2025
$3.26B
Change on fiscal 2024
+130.6%
Growth, 5 years
+24.4% a year
Highest on record
$3.26Bfiscal 2025
Lowest on record
$597.79Mfiscal 2019
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Kiniksa Pharmaceuticals International market cap, in more detail

Over the five fiscal years to 2025 the market cap grew at a compound 24.4% a year. Across the 7 fiscal year-ends on record (2019–2025), the highest was $3.26B in fiscal 2025 and the lowest $597.79M in fiscal 2019.

History · 7 fiscal years

Market cap at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Kiniksa Pharmaceuticals International market cap, year by year

Kiniksa Pharmaceuticals International (KNSA) market cap by fiscal year
Fiscal yearMarket capChangeYear endedShare price at year-endDiluted shares
Today$7.47B—$95.11—
2025$3.26B 130.6% up$41.2578.98M
2024$1.41B 12.0% up$19.7871.42M
2023$1.26B 19.6% up$17.5471.92M
2022$1.05B 30.7% up$14.9870.42M
2021$807.15M 26.1% down$11.7768.58M
2020$1.09B 82.8% up$17.6761.84M
2019$597.79M—$11.0654.05M
2018——$28.09—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

How to read it

It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.

Market cap at health care companies of similar size

Market cap of Kiniksa Pharmaceuticals International and comparable companies
CompanyMarket cap
Alkermes ALKS$7.64B
PACS Group PACS$7.71B
Kiniksa Pharmaceuticals International KNSA$7.47B
ImmunityBio IBRX$6.66B
Cytokinetics CYTK$7.20B
ABIVAX ABVX$7.19B

Today's market value as the market data feed reports it, each in the currency its shares trade in.

More on KNSA

Kiniksa Pharmaceuticals International, figure by figure

Kiniksa Pharmaceuticals International (KNSA) overview: price, valuation and scorecardAll health care companies by market value

Kiniksa Pharmaceuticals International market cap: questions and answers

What is Kiniksa Pharmaceuticals International's market cap?

Kiniksa Pharmaceuticals International (KNSA) has a market cap of $7.47B. At the end of fiscal 2025 (December 31, 2025) its market cap was $3.26B. That is 130.6% higher than the $1.41B of fiscal 2024.

What is the growth rate of Kiniksa Pharmaceuticals International's market cap?

Over the five fiscal years to 2025 the market cap grew at a compound 24.4% a year.

What are the highest and lowest market cap figures on record for Kiniksa Pharmaceuticals International?

Across the 7 fiscal year-ends on record (2019–2025), the highest was $3.26B in fiscal 2025 and the lowest $597.79M in fiscal 2019.

How is Kiniksa Pharmaceuticals International's market cap calculated?

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote. For Kiniksa Pharmaceuticals International it is on record here for 7 fiscal years, 2019 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Kiniksa Pharmaceuticals International (KNSA) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/KNSA/market-cap

Underlying data: the company's filings with the SEC and Yahoo Finance.